Novartis: what changed between November 8, 2025 and November 8, 2026

• net income$11.94 billion2024-12-31 to 2025-12-31→$13.97 billionfrom 2025-12-31 · valid: Two independent sources agree, or a primary source states it: the record asserts this claim. · sec.gov: 1 source, claim clm_8E9D1CC51F75
• operating income$14.54 billion2024-12-31 to 2025-12-31→$17.64 billionfrom 2025-12-31 · valid: Two independent sources agree, or a primary source states it: the record asserts this claim. · sec.gov: 1 source, claim clm_13AEEBEB19A6
• shares outstanding1.98 billion shares2024-12-31 to

Nothing began between the two days.

Nothing ended between the two days.

Unchanged (13)

13 claims held on both days: CEO 1, SEC CIK 1, fiscal year end 1, headquarters 1, listed on 2, registrant name 1, SIC industry 1, incorporated in 1, ticker 2, website 1, X 1.